Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exscientia Ltd ADR (NQ: EXAI )

4.680 -0.330 (-6.59%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 369,029
Open 4.950
Bid (Size) 4.650 (2)
Ask (Size) 4.850 (6)
Prev. Close 5.010
Today's Range 4.670 - 5.040
52wk Range 4.090 - 11.52
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
Investors are constantly on the hunt for undervalued, under-followed, and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance... 
Via Benzinga
Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday. 
Via Benzinga

Performance

YTD
-16.58%
-16.58%
1 Month
-20.68%
-20.68%
3 Month
-18.89%
-18.89%
6 Month
-13.97%
-13.97%
1 Year
-35.63%
-35.63%

More News

Read More
FedEx, Splunk, FactSet Research And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Topics Stocks
Exposures US Equities
A Preview Of Exscientia's Earnings
Via Benzinga
The Latest Analyst Ratings for Exscientia
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Exscientia Shares Surge On AI Collaboration: The Details
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Fresh Tracks Therapeutics Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Exscientia Announces AI Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany
From Exscientia plc
Via Business Wire
3 AI Drug Discovery Stocks to Watch
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Med Tech Stocks That the AI Boom Will Only Help
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Exscientia to Present at Upcoming Investor Conferences in September
From Exscientia plc
Via Business Wire
Biotech Breakthroughs: 3 Companies on the Cusp of Major Discoveries
Via InvestorPlace
Exscientia Business Update for Second Quarter and First Half of 2023
From Exscientia plc
Via Business Wire
3 AI Stocks Billionaires Are Loading Up On
Via InvestorPlace
Exscientia to Report Second Quarter 2023 Financial Results on August 10, 2023
From Exscientia
Via Business Wire
Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Millionaire-Maker Biotech Stocks to Buy Before the Window Closes
Via InvestorPlace
MarketBeat Week in Review – 7/24 - 7/28
Via MarketBeat
Topics Economy
Exposures Interest Rates
Biotech & Healthcare Meet AI: Stocks Soar On Innovation Potential
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Exscientia is the Sniper of the AI Drug Discovery Industry
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023
Via Benzinga
Exscientia Initiates Prospective Observational Study in Ovarian Cancer
From Exscientia
Via Business Wire
3 Biotech Stocks Using AI to Change Healthcare Forever
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.